Phero J C, Raj P P, McDonald J S
Department of Anesthesia, University of Cincinnati Medical Center, Ohio.
Dent Clin North Am. 1987 Oct;31(4):703-23.
The purpose of this article has been to discuss in detail both the rationale and techniques for TENS and myoneural injection therapy as modalities for the management of chronic myofascial pain. In a more subtle sense, we have also interjected some of our philosophy regarding the treatment of chronic myofascial pain. As was discussed earlier in the text of this article, very seldom, if ever, will any single technique stand alone as a "cure" for the patient with chronic pain, but, instead, each modality must be considered as an adjunctive form of multidisciplinary care. The multidisciplinary approach to pain management includes, as a minimum, pharmacotherapy, physical therapy, and behavioral medicine therapy. The concept of the team approach and goals of management, rather than cure, for chronic myofascial pain, cannot be overstated and is often as difficult to impart to the clinician as it is to the patient. To employ any individual form of therapy, the clinician must understand the indications and limitations of each modality in a total treatment program. Over the last several years TENS therapy has become extremely popular to a large extent because it is a noninvasive technique that most patients can be taught to use safely and effectively. An additional advantage to TENS therapy is that it provides many patients with some means of control over their pain, independent of medications and hands-on therapy by health care providers. Myoneural block therapy is often utilized to add a measure of control over the severe pain and dysfunction that may be present during the early phases of active treatment of chronic myofascial pain. It is used to enhance the effects of a conservative multidisciplinary pain management program when utilized on a short-term basis. Myoneural block therapy is often a useful adjunct to physical therapy to improve the patient's overall range of motion and facilitate either treatment by the physical therapist or a home exercise program. The clinician is reminded that myoneural injection therapy can be overutilized. It should be limited as to the number of injections per visit. Also, the total number of visits the patient receives injections should be kept low. After the initial myoneural injection treatment series of three to five sessions, it should be utilized only for severe pain exacerbation that has been unresponsive to conservative, noninvasive management.
本文的目的是详细讨论经皮电刺激神经疗法(TENS)和肌神经注射疗法作为慢性肌筋膜疼痛管理方式的基本原理和技术。从更微妙的意义上讲,我们还融入了一些我们对于慢性肌筋膜疼痛治疗的理念。正如本文前文所讨论的,对于慢性疼痛患者而言,极少有单一技术能独立成为“治愈”方法,相反,每种方式都应被视为多学科护理的辅助形式。疼痛管理的多学科方法至少包括药物治疗、物理治疗和行为医学治疗。团队治疗方法以及慢性肌筋膜疼痛管理而非治愈的目标,怎么强调都不为过,而且向临床医生传达这一点往往和向患者传达一样困难。要采用任何一种单独的治疗形式,临床医生必须了解每种方式在整个治疗方案中的适应症和局限性。在过去几年里,经皮电刺激神经疗法在很大程度上变得极其流行,因为它是一种非侵入性技术,大多数患者能够学会安全有效地使用。经皮电刺激神经疗法的另一个优点是,它为许多患者提供了某种控制疼痛的方法,独立于药物以及医疗保健人员的手动治疗。肌神经阻滞疗法常用于在慢性肌筋膜疼痛积极治疗的早期阶段,增加对可能出现的严重疼痛和功能障碍的控制措施。短期使用时,它用于增强保守多学科疼痛管理方案的效果。肌神经阻滞疗法通常是物理治疗的有用辅助手段,可改善患者的整体活动范围,并促进物理治疗师的治疗或家庭锻炼计划。临床医生需谨记,肌神经注射疗法可能会被过度使用。每次就诊的注射次数应加以限制。此外,患者接受注射的就诊总次数也应保持在较低水平。在最初进行三至五次的肌神经注射治疗系列后,仅应在对保守、非侵入性管理无反应的严重疼痛加剧时使用。